Heart Failure Care Beyond City Limits: Insights from a Cardiologist

Implementation of STRONG-HF protocol in heart failure management: an Australian perspective

Unleashing the Power of STRONG-HF: Enabling Transformation in Heart Failure Management Across China

Screening & Diagnosis of Heart Failure in Pre-Diabetic and Diabetic Patients

Elevating CVD management in APAC to its Zenith- with Cardiac biomarkers 

Quantum leap in reducing rehospitalization in HF by 70-80% – How and where?

STRONG-HF: Rapid Uptitration of Guideline Directed Medical Therapy for Heart Failure

Guidelines Interpretation – Guidelines for the management of chronic heart failure in dialysis patients in China

Heart failure management in Australia and the role of NT-proBNP in monitoring and treatment

Download APAC STRONG-HF Master Pack: First-hand Insights from Prof Mebazaa on Heart Failure Treatment Monitoring

Heart Failure Management in India – Overcoming Present Challenges

STRONG-HF study highlighting benefits of treatment optimisation

STRONG-HF: Post-discharge Heart Failure Management and Implementation of GDMT Heart Failure Therapy

NT-proBNP and ECHO in heart failure – do they always go hand in hand?

Clinical Application Value of NT-proBNP in Chronic Kidney Diseases Patients with Cardiovascular Diseases

Management of Diabetes in Japan – Can Patients Play a More Significant Role?

T2DM Patient Support Program in Hong Kong and the Value of NT-proBNP

NT-proBNP: Increasing Clinical Confidence in Heart Failure Management

What is the Peptide for Life initiative?

Heart Failure in Asia – Present Challenges and Future Strategies

Heart Failure Prevention in T2DM – Essence of JCS/JDS joint consensus

2800+ Healthcare Professionals have cardiac insights delivered to their inbox
Sign up to receive the latest updates via your email
Keep me informed